insights_auto
Why is GNMSF down 3.46%?
Dive Deeperchevron_right
GNMSF:OTCMKTS
Genmab A/S
$503.74
arrow_downward
-3.46%(-18.06) 1D
Nov 19, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GNMSF...
Open
$503.74
High
$503.74
Low
$503.74
Mkt. cap
32.44B
Avg. vol.
2.08K
Volume
131.00
52-wk high
$581.00
52-wk low
$232.50
Beta
0.61
Shares outstanding
62.57M
No. of employees
3K
Open
$503.74
High
$503.74
Low
$503.74
Mkt. cap
32.44B
Avg. vol.
2.08K
Volume
131.00
52-wk high
$581.00
52-wk low
$232.50
Beta
0.61
Shares outstanding
62.57M
No. of employees
3K
News stories
From web sources and news partners
MedWatch
·
1 day ago
Novartis raises sales forecast for Genmab-developed MS drug Kesimpta
Investing.com India
·
1 day ago
Genmab at Jefferies Global Healthcare Conference: pipeline turns By Investing.com
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S
CEOJan G. J. van de Winkel
Employees3.24K
Founded1999
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitegenmab.com